Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 26 May | 118.75 |
-1.70 (-1.41%) |
OPEN
118.10 |
HIGH
119.90 |
LOW
114.45 |
| NSE 00:00 | 26 May | 118.80 |
-1.70 (-1.41%) |
OPEN
117.60 |
HIGH
119.75 |
LOW
114.50 |
| OPEN | 118.10 |
| PREVIOUS CLOSE | 120.45 |
| VOLUME | 10345 |
| 52-Week high | 267.20 |
| 52-Week low | 50.70 |
| P/E | 7.92 |
| Mkt Cap.(Rs cr) | 341 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lyka Labs Ltd. (LYKALABS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 900.55 | -1.16 | 966.90 | 652.75 | 216068.95 |
| Divi's Lab. | 3449.15 | -1.98 | 5425.00 | 3365.10 | 91557.69 |
| Cipla | 964.40 | -0.72 | 1083.15 | 850.00 | 77807.79 |
| Dr Reddy's Labs | 4307.25 | 0.05 | 5613.65 | 3655.00 | 71681.25 |
| Apollo Hospitals | 3668.00 | 4.03 | 5930.70 | 3122.90 | 52738.50 |
| Torrent Pharma. | 2900.90 | 10.11 | 3304.45 | 2485.00 | 49089.03 |
| Gland Pharma | 2853.25 | 4.00 | 4350.00 | 2679.00 | 46964.49 |
| Piramal Enterp. | 1855.90 | 2.47 | 3013.00 | 1688.00 | 44291.05 |
| Biocon | 325.35 | 0.26 | 420.25 | 314.90 | 39061.52 |
| Zydus Lifesci. | 372.85 | 1.80 | 668.85 | 319.40 | 38168.66 |
| Abbott India | 17698.85 | -2.04 | 23902.30 | 15525.00 | 37610.06 |
| Alkem Lab | 3024.35 | 1.91 | 4067.70 | 2835.00 | 36156.10 |
| Max Healthcare | 367.50 | 2.90 | 472.60 | 205.00 | 35633.90 |
| Aurobindo Pharma | 535.50 | 2.36 | 1043.00 | 514.50 | 31374.95 |
| Laurus Labs | 559.20 | 0.95 | 723.55 | 433.20 | 30048.61 |
| Lupin | 600.75 | 1.77 | 1267.50 | 583.05 | 27304.09 |
| Glaxosmi. Pharma | 1513.25 | -0.78 | 1917.00 | 1433.05 | 25635.97 |
| Ipca Labs. | 917.15 | -2.22 | 1383.55 | 909.00 | 23268.10 |
| Syngene Intl. | 527.40 | -0.28 | 699.95 | 508.10 | 21171.42 |
| Pfizer | 4247.95 | -0.33 | 6164.80 | 4077.80 | 19434.37 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
